title: The protocol for a European double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: the CAPP study. Concerted Action Polyposis Prevention.
authors.affiliation: CAPP Study Coordinating Centre, Dept Human Genetics, University of Newcastle upon Tyne, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Burn
authors.forename: P D
authors.initials: PD
authors.lastname: Chapman
authors.forename: J
authors.initials: J
authors.lastname: Mathers
authors.forename: L
authors.initials: L
authors.lastname: Bertario
authors.forename: D T
authors.initials: DT
authors.lastname: Bishop
authors.forename: S
authors.initials: S
authors.lastname: Bülow
authors.forename: J
authors.initials: J
authors.lastname: Cummings
authors.forename: R
authors.initials: R
authors.lastname: Phillips
authors.forename: H
authors.initials: H
authors.lastname: Vasen
mesh_terms: D011125:Adenomatous Polyposis Coli / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002985:Clinical Protocols; D003113:Colonoscopy; D004040:Dietary Carbohydrates / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D013213:Starch / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004040:Dietary Carbohydrates; D013213:Starch; D001241:Aspirin